aBravo Is a Novel Aedes aegypti Antiviral Protein that Interacts with, but Acts Independently of, the Exogenous siRNA Pathway Effector Dicer 2. (2020)
Attributed to:
Arthropod-borne infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/v12070748
PubMed Identifier: 32664591
Publication URI: http://europepmc.org/abstract/MED/32664591
Type: Journal Article/Review
Volume: 12
Parent Publication: Viruses
Issue: 7
ISSN: 1999-4915